AKI: Clinical Trials

1 trial for AKI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow AKI: new trials by email Literature Review of AKI trials Research Report on AKI

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
anti-pseudomonal cephalosporin, anti-pseudomonal penicillin - Sepsis, AKI
Phase 4CompletedVanderbilt University Medical Center26342021-11-102023-12-22

Narrower conditions

Neurotoxicity Syndromes (1)  ·  Sepsis (1)

Broader conditions

Chemically-Induced Disorders (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Poisoning (1)  ·  Systemic Inflammatory Response Syndrome (1)

Sponsors

Vanderbilt University Medical Center (1)

Countries

United States (1)

Top investigators

Edward T Qian, MD (1)

Results publications

PMID 36898748, PMID 37837651